相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect
D. M. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial
V. Hebert et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy A Post Hoc Analysis of a Randomized Clinical Trial
Claire Mignard et al.
JAMA DERMATOLOGY (2020)
Incidence and Mortality of Pemphigus in France
Lamia Jelti et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Update of the French recommendations for the management of pemphigus
L. Jelti et al.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE (2019)
Large International Validation of ABSIS and PDAI Pemphigus Severity Scores reg
Vivien Hebert et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Sixteen-year history of rituximab therapy for 1085 pemphigus vulgaris patients: A systematic review
Soheil Tavakolpour et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Rituximab as Single Long-term Maintenance Therapy in Patients With Difficult-to-Treat Pemphigus
Julia Sanchez et al.
JAMA DERMATOLOGY (2018)
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
Pascal Joly et al.
LANCET (2017)
Pemphigus
Michael Kasperkiewicz et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus
C. Boulard et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany
Franziska Huebner et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
First-line Treatment of Pemphigus Vulgaris With a Combination of Rituximab and High-Potency Topical Corticosteroids
Saskia Ingen-Housz-Oro et al.
JAMA DERMATOLOGY (2015)
Pemphigus. S2 Guideline for diagnosis and treatment - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV)
M. Hertl et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
The development and validation of the Treatment of Autoimmune Bullous Disease Quality of Life questionnaire, a tool to measure the quality of life impacts of treatments used in patients with autoimmune blistering disease
A. Tjokrowidjaja et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids
Naif Almugairen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2013)
Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
Natacha Colliou et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Development of a Quality-of-Life Instrument for Autoimmune Bullous Disease The Autoimmune Bullous Disease Quality of Life Questionnaire
Deshan F. Sebaratnam et al.
JAMA DERMATOLOGY (2013)
Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients
M. Kasperkiewicz et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Combined treatment with immunoadsorption and rituximab leads to fast and prolonged clinical remission in difficult-to-treat pemphigus vulgaris
M. Behzad et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Therapy with rituximab for autoimmune pemphigus: Results from a single-center observational study on 42 cases with long-term follow-up
Giuseppe Cianchini et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011
S. J. Meggitt et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis)
Pascal Joly et al.
CLINICS IN DERMATOLOGY (2011)
Clinical Characterization of Melanoma patients with and without activating BRAF Mutation
M. Schlaak et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2011)
Autoimmune bullous skin diseases. Part 1: Clinical manifestations
Andrea Kneisel et al.
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2011)
A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus
Linda K. Martin et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2011)
Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients
Enno Schmidt et al.
EXPERIMENTAL DERMATOLOGY (2010)
Treating Pemphigus Vulgaris with Prednisone and Mycophenolate Mofetil: A Multicenter, Randomized, Placebo-Controlled Trial
Stefan Beissert et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Rituximab in Severe Pemphigus
Enno Schmidt et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
ELISA Testing of Anti–Desmoglein 1 and 3 Antibodies in the Management of Pemphigus
Claire Abasq et al.
ARCHIVES OF DERMATOLOGY (2009)
A randomized double-blind trial of intravenous immunoglobulin for pemphigus
Masayuki Amagai et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris
Victoria P. Werth et al.
ARCHIVES OF DERMATOLOGY (2008)
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
Dedee E. Murrell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
A single cycle of rituximab for the treatment of severe pemphigus
Pascal Joly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus
Stefan Beissert et al.
ARCHIVES OF DERMATOLOGY (2006)
Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin
A. Razzaque Ahmed et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels
KE Harman et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
分享论文
